XML 31 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating expenses    
General and administrative $ 1,352,035 $ 1,761,307
Research and development 6,348,668 5,712,210
Total operating expenses (7,700,703) (7,473,517)
Other income (expenses)    
Grant income 74,944 74,528
Research and development incentive income 943,215 413,682
Interest income, net 46,720 78,800
Foreign exchange gain (loss), net 53,113 (4,507)
Total other income, net 1,117,992 562,503
Net loss before provision for income taxes (6,582,711) (6,911,014)
Income tax expense, current (9,214) (8,717)
Net loss and comprehensive loss $ (6,591,925) $ (6,919,731)
Net Loss per share    
Basic and diluted (in dollars per share) $ (0.12) $ (0.15)
Weighted average number of shares outstanding    
Basic and diluted (in shares) 54,773,685 46,327,482